Cargando…
Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry
Alzheimer disease (AD) is a leading cause of dementia that has gained prominence in our aging society. Yet, the complexity of diagnosing AD and measuring its invasiveness poses an obstacle. To this end, blood-based biomarkers could mitigate the inconveniences that impede an accurate diagnosis. We de...
Autores principales: | Kim, Yeongshin, Kim, Jaenyeon, Son, Minsoo, Lee, Jihyeon, Yeo, Injoon, Choi, Kyu Yeong, Kim, Hoowon, Kim, Byeong C., Lee, Kun Ho, Kim, Youngsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786819/ https://www.ncbi.nlm.nih.gov/pubmed/35075217 http://dx.doi.org/10.1038/s41598-022-05384-8 |
Ejemplares similares
-
Web portal for analytical validation of MRM-MS assay abided with integrative multinational guidelines
por: Kim, Jaenyeon, et al.
Publicado: (2020) -
Proteome Multimarker
Panel for the Early Detection
of Hepatocellular Carcinoma: Multicenter Derivation, Validation, and
Comparison
por: Kim, Ju Yeon, et al.
Publicado: (2022) -
Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma
por: Yeo, Injoon, et al.
Publicado: (2020) -
Network analysis of plasma proteomes in affective disorders
por: Rhee, Sang Jin, et al.
Publicado: (2023) -
Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)